If your asthma flares in the summer and fall, your eczema gets worse without explanation, or you live or work in a damp building, a single mold can be part of the picture. This test looks for a specific antibody your body makes when it reacts to Mucor racemosus, one of several common indoor molds that show up in fungal allergy panels.
Mucor racemosus on its own does not cause every allergy symptom. But missing it can leave you with the wrong story about what is driving your breathing, skin, or sinus problems, especially if your standard allergy testing focused only on the most familiar molds.
This test measures IgE (immunoglobulin E), a class of antibody your immune system uses for allergic reactions, that is specifically aimed at proteins from the mold Mucor racemosus. The result tells you whether your immune system has been sensitized to this particular mold.
Sensitization is not the same as a confirmed allergy. It means your body recognizes the mold and is set up to react to it. Whether you actually have symptoms when exposed depends on how high your antibody level is, how much mold you encounter, and your overall allergic profile.
Standard allergy panels often focus on the most common molds (Alternaria, Cladosporium, Aspergillus) and may not include Mucor racemosus. In a pediatric allergy clinic that tested IgE to 16 different fungi, the best three-fungus combination for catching overall fungal sensitization was Cladosporium herbarum, Penicillium notatum, and Mucor racemosus. A panel that skips Mucor can miss people who are genuinely sensitized to molds.
In a separate study of asthmatic children, adding Mucor and other less-common molds to the testing panel uncovered patients whose mold sensitivity would have been missed by a more limited panel. The lesson: a normal result on a basic mold test does not mean every mold is in the clear.
In children with fungal IgE positivity (where Mucor racemosus was part of the testing panel), asthma tended to be more severe, with notable worsening in the summer and fall when mold spore counts climb. Fungal sensitization was also strongly linked to eczema in the same children.
In adults with asthma, fungal sensitization (including to Mucor racemosus) was associated with higher total IgE and a different inflammatory pattern marked by elevated IL-17A, an immune signaling molecule. That pattern, in turn, predicted more emergency department visits for asthma. Across severe asthma cohorts more broadly, around 66% of patients are sensitized to at least one fungus, supporting the idea that fungal sensitization is a treatable feature in difficult-to-control asthma.
Children with fungal IgE positivity had a stronger association with eczema than with rhino-conjunctivitis (allergy symptoms in the nose and eyes). In adults with atopic dermatitis, sensitization to molecular components of molds (Aspergillus, Cladosporium, Penicillium, and the yeast Malassezia) tracked with more severe skin disease and a higher chance of also having asthma or allergic rhinitis.
Mucor racemosus can occasionally play a role in severe systemic allergic reactions. A case report described an anaphylactic reaction in an atopic infant whose testing showed a strongly positive skin response to Mucor racemosus, illustrating that this mold is capable of driving more than just nuisance symptoms in highly sensitized individuals.
In a dataset of about 1.6 million patients tested for 17 different fungi, IgE responses to one mold strongly tracked with responses to closely related molds. Mucor racemosus, for example, clusters with Rhizopus (another Mucorales fungus) and shares antibody reactivity with it. Across all tests, Alternaria positivity ran around 16.6% and Cladosporium around 11.1%, with Mucor falling within the range observed for the other species tested.
What this means for you: a positive Mucor racemosus IgE is best read as pointing to a family of related molds your body reacts to, rather than naming one exact culprit. That changes how you should think about avoidance and treatment, since exposure to one mold often comes packaged with several others in the same environment.
Mucor racemosus IgE is a research and exploratory marker without standardized clinical cutpoints universally agreed upon by guideline bodies. Most labs report results in kU/L (kilounits per liter) using ImmunoCAP or similar platforms, and the assay sets the analytical detection range. Different labs and different methods can give different numbers from the same blood sample, so always interpret your results within the context of the lab that ran them.
The general framework most allergy labs use for any allergen-specific IgE looks like this:
| Class | Range (kU/L) | What It Suggests |
|---|---|---|
| Class 0 | Less than 0.10 | No detectable sensitization |
| Class 1 | 0.10 to 0.70 | Low-level sensitization |
| Class 2-3 | 0.70 to 17.5 | Moderate sensitization |
| Class 4-6 | Greater than 17.5 | High to very high sensitization |
These categories are platform-specific reference labels rather than a guideline-endorsed risk threshold for Mucor racemosus specifically. A higher class generally means a stronger antibody response, which often (but not always) correlates with a stronger clinical reaction. The level alone does not diagnose allergy. It must be paired with your symptoms and exposure history.
A single Mucor racemosus IgE reading is a snapshot. Sensitization can change over years as exposure shifts, immune responses mature, or treatments take effect. The most useful thing this test can do is establish a baseline and let you see how your number moves over time.
A practical cadence: get a baseline now, retest in 6 to 12 months if you are making changes (moving out of a damp environment, treating a chronic mold exposure, starting an allergy treatment plan), and at least annually if your symptoms are ongoing. If your level is rising even though you have not changed your environment, that is information worth bringing to an allergist.
A positive Mucor racemosus IgE is a starting point, not an end point. The most useful next steps are: pair it with a full mold panel (Alternaria, Cladosporium, Aspergillus, Penicillium, and others) so you can see whether your sensitization is broad or narrow; check total IgE and eosinophils to gauge your overall allergic load; and review your home and work environment for damp areas, water damage, or visible mold.
If the result lines up with symptoms (asthma that flares in damp seasons, eczema that worsens in certain rooms, sinus issues you cannot pin down), an allergist can confirm clinical relevance with skin testing, decide whether environmental remediation will move the needle, and discuss whether allergen-targeted treatment makes sense. If the result is positive but you have no symptoms, the value is mainly in knowing you carry a sensitization that may matter later.
Mucor racemosus IgE is one piece of a fungal allergy picture. If your number is meaningfully elevated and you have asthma, severe eczema, or chronic sinus disease, the result is worth bringing to an allergist or pulmonologist along with a broader mold panel and total IgE. In severe asthma especially, identifying fungal sensitization can shift management toward addressing mold exposure and considering antifungal or anti-inflammatory strategies tailored to that pattern.
Mucor Racemosus Mold IgE is best interpreted alongside these tests.